A Ludwig Cancer Research study led by Benoit Van den Eynde, Director of Ludwig Brussels, has identified a novel mechanism by which tumours of the aggressive skin cancer melanoma can resist cancer immunotherapy. Their paper, which appears in Nature...
Original Article: Ludwig researchers uncover novel mechanism by which tumours evade cancer immunotherapies
NEXT ARTICLE